Cargando…
DICER1 Syndrome: DICER1 Mutations in Rare Cancers
DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the f...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977116/ https://www.ncbi.nlm.nih.gov/pubmed/29762508 http://dx.doi.org/10.3390/cancers10050143 |
_version_ | 1783327308430442496 |
---|---|
author | Robertson, Jake C. Jorcyk, Cheryl L. Oxford, Julia Thom |
author_facet | Robertson, Jake C. Jorcyk, Cheryl L. Oxford, Julia Thom |
author_sort | Robertson, Jake C. |
collection | PubMed |
description | DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed. |
format | Online Article Text |
id | pubmed-5977116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59771162018-05-31 DICER1 Syndrome: DICER1 Mutations in Rare Cancers Robertson, Jake C. Jorcyk, Cheryl L. Oxford, Julia Thom Cancers (Basel) Review DICER1 syndrome is a rare genetic disorder that predisposes individuals to multiple cancer types. Through mutations of the gene encoding the endoribonuclease, Dicer, DICER1 syndrome disrupts the biogenesis and processing of miRNAs with subsequent disruption in control of gene expression. Since the first description of DICER1 syndrome, case reports have documented novel germline mutations of the DICER1 gene in patients with cancers as well as second site mutations that alter the function of the Dicer protein expressed. Here, we present a review of mutations in the DICER1 gene, the respective protein sequence changes, and clinical manifestations of DICER1 syndrome. Directions for future research are discussed. MDPI 2018-05-15 /pmc/articles/PMC5977116/ /pubmed/29762508 http://dx.doi.org/10.3390/cancers10050143 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Robertson, Jake C. Jorcyk, Cheryl L. Oxford, Julia Thom DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title | DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title_full | DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title_fullStr | DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title_full_unstemmed | DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title_short | DICER1 Syndrome: DICER1 Mutations in Rare Cancers |
title_sort | dicer1 syndrome: dicer1 mutations in rare cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977116/ https://www.ncbi.nlm.nih.gov/pubmed/29762508 http://dx.doi.org/10.3390/cancers10050143 |
work_keys_str_mv | AT robertsonjakec dicer1syndromedicer1mutationsinrarecancers AT jorcykcheryll dicer1syndromedicer1mutationsinrarecancers AT oxfordjuliathom dicer1syndromedicer1mutationsinrarecancers |